Max Woolley

Renishaw (United Kingdom), University of Bristol

Papers

3

Total Citations

183

H-Index

3

About

Max Woolley is a leading figure in the intersection of neurosurgery and robotics, with a primary focus on overcoming the blood-brain barrier (BBB) to improve outcomes for patients with devastating brain cancers. His seminal work on convection-enhanced delivery (CED) of carboplatin, as detailed in his most-cited papers (totaling over 160 citations), demonstrates a pioneering approach to bypassing the BBB for both advanced brainstem glioma and recurrent glioblastoma. By integrating robotic guidance and a novel implantable catheter system, Woolley has advanced the precision and feasibility of targeted chemotherapy delivery, directly addressing a critical failure point in systemic treatment. Beyond oncology, his expertise extends to functional neurosurgery, where he has contributed to the refinement of “asleep” deep brain stimulation (DBS) techniques. His 2020 study on 226 consecutive DBS electrodes placed using the Neuro|MateTM robot underscores his commitment to enhancing accuracy and reproducibility in movement disorder treatments. Woolley’s work not only pushes the boundaries of drug delivery and surgical robotics but also offers tangible hope for improving patient prognoses in some of the most challenging neurological conditions.

Research Focus

Key Achievements

3
H-Index
3
Papers
183
Total Citations
61
Avg Citations/Paper
🏆 Most Cited Paper
Robot-guided convection-enhanced delivery of carboplatin for advanced brainstem glioma
89 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Renishaw (United Kingdom), University of Bristol

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago